Literature DB >> 6194810

Treatment of keratoacanthoma with intralesional bleomycin.

S Sayama, H Tagami.   

Abstract

Six patients with keratoacanthoma were successfully treated with intralesional injection of bleomycin. This new therapy produced a marked shortening of the clinical course without any complications.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6194810     DOI： 10.1111/j.1365-2133.1983.tb04619.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  6 in total

1.  Treatment of multiple keratoacanthomas with erlotinib.

Authors:  David C Reid; Joan Guitart; Mark Agulnik; Mario E Lacouture
Journal:  Int J Clin Oncol       Date:  2010-03-11       Impact factor: 3.402

2.  The Effectiveness of Cryosurgery Combined with Curettage and Electrodessication in the Treatment of Keratoacanthoma: A Retrospective Analysis of 90 Cases.

Authors:  Antonios Panagiotopoulos; Nikolaos Kyriazis; Eleni Polychronaki; George D Leotsakos; Polytimos Vassis; Dimitrios Rigopoulos
Journal:  Indian J Dermatol       Date:  2020 Sep-Oct       Impact factor: 1.494

3.  Subungual keratoacanthoma.

Authors:  D W Levy; A Bonakdarpour; P B Putong; M Mesgarzadeh; R R Betz
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

4.  Recurrent facial keratoacanthoma in a patient with diabetes: a case report.

Authors:  Esam Omar
Journal:  BMC Res Notes       Date:  2014-04-23

Review 5.  Intralesional Agents in Dermatology: Pros and Cons.

Authors:  Jagdish Sakhiya; Dhruv Sakhiya; Jitesh Kaklotar; Bansi Hirapara; Madhav Purohit; Krishna Bhalala; Feral Daruwala; Nimish Dudhatra
Journal:  J Cutan Aesthet Surg       Date:  2021 Jul-Sep

6.  Keratoacanthoma: an unusual nasal mass.

Authors:  M S Sazafi; H Salina; A Asma; N Masir; S H A Primuharsa Putra
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-12       Impact factor: 2.124
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.